Annalisa Varrasso Clinical Oncology Society of Australia Annual Scientific Meeting 2023

Annalisa Varrasso

Senior Medical Science Liaison for oncology at Merck Healthcare Australia

Abstracts this author is presenting:

• SPADE: Design of a real-world observational study of avelumab first-line maintenance (1LM) in advanced urothelial carcinoma (UC) in the Asia-Pacific (APAC) region — Lunch, Poster Viewing, Exhibition & COSA Group Meetings
• Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia — Lunch, Poster Viewing, Exhibition & COSA Group Meetings
• Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): long-term outcomes from the JAVELIN Bladder 100 trial in older patients — Lunch, Poster Viewing, Exhibition & COSA Group Meetings
• Treatment patterns and criteria used to determine platinum eligibility in metastatic urothelial cancer: a real-world survey in Australia — Lunch, Poster Viewing, Exhibition & COSA Group Meetings